India's most comprehensive portal on pharmaceutical News, …
WEB3 days ago · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Centralized certificate registration & renewal process to begin in ...
WEBDec 22, 2023 · Centralized certificate registration & renewal process to begin in Bihar as SPC is locked in litigation: Peethaambaran Kunnathoor, Chennai Friday, December 22, 2023, 08:00 Hrs [IST]
CPHI & PMEC India: Gateway to global pharma market
WEBNov 30, 2023 · CPHI & PMEC India: Gateway to global pharma market. AD Pradeep Kumar. Thursday, November 30, 2023, 08:00 Hrs [IST] The Indian pharma has taken giant strides in the global market in the last four decades. This impressive growth has led India to gain the distinction of “Pharmacy of the world”. Indian pharmaceutical companies played a …
Glenmark's diabetes drug candidate gets intl non-proprietary …
WEBGlenmark Pharmaceuticals Limited, one of India's leading research-led, integrated pharmaceutical companies based in Mumbai, has received the international non-proprietary name (INN) 'Melogliptin' for its lead type II diabetes drug candidate GRC 8200, from the World Health Organization (WHO). This name was selected during the recently held 45th ...
Himalaya bags first-ever US patent for a certified herbal …
WEBNandita Vijay, Bangalore | Thursday, November 27, 2008, 08:00 Hrs [IST] Himalaya has bagged a US patent for its product Picrolax for bowel management. The product which is now introduced in the domestic market is the first US patent certified herbal formulation from the company. US patent certification is given for the laxative property of the ...
Clinical trials in India – a reality check - Pharmabiz.com
WEBClinical trials are studies conducted in human volunteers to better treat or prevent diseases and determine whether the new treatment is both safe and effective. Such trials are approved by the regulatory agency of the Government and undertaken only after there is adequate evidence from animal experiments for their safety and efficacy.
Lupin receives US FDA tentative approval for generic Xarelto tablets
WEBWednesday, January 24, 2024, 11:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg, to market a generic equivalent of Xarelto ...
Telix to expand US footprint with acquisition of Texas-based ...
WEBWednesday, February 28, 2024, 09:00 Hrs [IST] Telix has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry ...
Fresenius Kabi to acquire APP Pharmaceuticals for US$ 3.7 billion
WEBBased on the cash purchase price, the transaction values the fully diluted equity capital of APP at approximately US$ 3.7 billion. Fresenius expects the acquisition to be neutral to EPS in the first year and clearly accretive from the second year onwards. The acquisition is an important step in Fresenius Kabi's growth strategy.
Eli Lilly announces positive topline results from the SURMOUNT-1 …
WEBAug 22, 2024 · Indianapolis. Thursday, August 22, 2024, 13:00 Hrs [IST] Eli Lilly and Company announced positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating the efficacy and safety of tirzepatide (Zepbound and Mounjaro) once weekly for long-term weight management and delay in progression to diabetes in adults ...